72 results on '"Tsimikas, Sotirios"'
Search Results
2. Abstract 4140798: Genome-Wide Association Studies (GWAS) of Angiotensinogen Levels in the Multi-Ethnic Study of Atherosclerosis (MESA)
3. Abstract 4140204: Relationship of Oxidized Phospholipids and Lp(a) to Outcomes after Acute Coronary Syndrome: A Post Hoc Analysis of the ODYSSEY OUTCOMES Trial
4. Abstract 4138935: Lp(a) and LDL-Cholesterol Interaction Association with Aortic Valve Calcium and Severe Aortic Stenosis
5. Abstract 4135861: Lipoprotein(a) and Its Impact on Left Ventricular Remodeling Over a Decade: The Multi-Ethnic Study of Atherosclerosis
6. Abstract 4124446: Traditional Risk Factors, Cardiovascular Health, and Elevated Lipoprotein(a): The Multi-Ethnic Study of Atherosclerosis
7. Abstract 4119560: Oxidized Phospholipids and Calcific Aortic Valvular Disease
8. Lipoprotein(a) in the Year 2024: A Look Back and a Look Ahead
9. Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation
10. Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease
11. Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease
12. Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
13. Abstract 17748: Lipoprotein(a) and Oxidized Phospholipids on Lipoproteins and Cardiovascular Outcomes in Patients With Chronic Coronary Syndrome Treated With Colchicine
14. Abstract 17395: Effect of ION904, an Antisense Inhibitor of Angiotensinogen Production: Results of Phase 1 and Phase 2 Pilot Studies
15. Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification
16. Abstract 12126: Trends in Lipoprotein(a) Testing in Individuals With Cardiovascular Disease
17. Abstract 11374: Aspirin for Primary Prevention of Cardiovascular Events in Patients With Elevated Lipoprotein(a): The Multi-Ethnic Study of Atherosclerosis
18. Abstract 11309: Lipoprotein(a) and the Pooled Cohort Equations for Risk Prediction: The Multi-Ethnic Study of Atherosclerosis
19. Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency
20. PCSK9 Activity Is Potentiated Through HDL Binding
21. Intracellular AIBP (Apolipoprotein A-I Binding Protein) Regulates Oxidized LDL (Low-Density Lipoprotein)-Induced Mitophagy in Macrophages
22. Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels
23. The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia
24. The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia
25. Abstract 13913: Single Dose Safety, Pharmacokinetics, and Pharmacodynamics of a Potent PCSK9 Synthesis Inhibitor, AZD8233, in Subjects With Elevated Ldl Cholesterol
26. Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
27. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial
28. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial
29. Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked to Human Coronary Atherosclerosis
30. Lipid-Lowering Agents: Targets Beyond PCSK9
31. Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis
32. RNA-targeted therapeutics for lipid disorders
33. Plasma Proteomics for Epidemiology: Increasing Throughput With Standard-Flow Rates
34. The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting
35. Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins
36. Novel Lipoprotein(a) Catabolism Pathway via Apolipoprotein(a) Recycling: Adding the Plasminogen Receptor PlgRKT to the List
37. Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients
38. Elevated Lp(a) and Abdominal Aortic Aneurysm: An Intriguing Association That Needs Confirmation With Well-Designed Studies
39. LPA Gene, Ethnicity, and Cardiovascular Events
40. Novel Kidney Injury Biomarkers may Help Predict the Clinical Response to Renal Artery Stenting: C-003
41. Retrieval of a detached transseptal sheath tip from a right pulmonary artery branch following catheter ablation
42. ‘LDL-C’ = LDL-C + Lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin/kexin type 9 era of potent LDL-C lowering
43. Manganese G8 Dendrimers Targeted to Oxidation-Specific Epitopes: In Vivo MR Imaging of Atherosclerosis
44. What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis?
45. The Association Between Circulating Lipoprotein(a) and Type 2 Diabetes: Is It Causal?
46. Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics
47. Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis
48. Adaptive immunity in atherogenesis: new insights and therapeutic approaches
49. Emerging therapeutic agents to lower lipoprotein (a) levels
50. Immunohistochemical Staining for Oxidized Phospholipids in Patients with NAFLD/NASH: 1518
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.